Home › Stocks › GELS

GELS — GELTEQ LIMITED

Reported value held$24.45K
Funds holding (latest)4
SectorHealth Care
Funds holding (Q2 2026)3
Institutional value$17.81K · 26.58K sh
New / Add / Cut / Exit1 / 0 / 2 / 1
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +3.4% (+866 sh)
Institutional value change Up +5.7%

As of Q2 2026, 3 SEC-registered investment managers reported holding GELS (GELTEQ LIMITED) in their latest 13F filings, with a combined reported value of $17.81K across 26.58K shares. That is +3.4% by share count (+866 shares) versus the previous quarter, while reported value moved +5.7%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 1 opened new positions, 2 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

GELS is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

FundQuarterSharesValuePortfolio WeightChange
Morgan Stanley history Q2 2026 15.00K $10.05K 0.00% New
Citadel Advisors history Q2 2026 11.46K $7.68K 0.00% Reduce
Two Sigma Investments history Q1 2026 10.05K $6.64K 0.00% Reduce
UBS Group AG history Q2 2026 125 $83 0.00% Reduce

New Positions (Q2 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 4 funds)

FundQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Morgan Stanley — 3.50K — 651 — — 15.00K
Citadel Advisors 23.75K 15.16K 23.20K — — 13.83K 11.46K
UBS Group AG 6.20K 23.45K 5.54K 952 — 1.83K 125
Two Sigma Investments — — — — 51.36K 10.05K —

Download holders (CSV)